1. Home
  2. FGEN vs CYN Comparison

FGEN vs CYN Comparison

Compare FGEN & CYN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FGEN
  • CYN
  • Stock Information
  • Founded
  • FGEN 1993
  • CYN 2013
  • Country
  • FGEN United States
  • CYN United States
  • Employees
  • FGEN N/A
  • CYN N/A
  • Industry
  • FGEN Biotechnology: Pharmaceutical Preparations
  • CYN EDP Services
  • Sector
  • FGEN Health Care
  • CYN Technology
  • Exchange
  • FGEN Nasdaq
  • CYN Nasdaq
  • Market Cap
  • FGEN 45.1M
  • CYN 42.0M
  • IPO Year
  • FGEN 2014
  • CYN 2021
  • Fundamental
  • Price
  • FGEN $11.12
  • CYN $4.76
  • Analyst Decision
  • FGEN Strong Buy
  • CYN
  • Analyst Count
  • FGEN 2
  • CYN 0
  • Target Price
  • FGEN $146.50
  • CYN N/A
  • AVG Volume (30 Days)
  • FGEN 24.8K
  • CYN 1.6M
  • Earning Date
  • FGEN 11-03-2025
  • CYN 11-05-2025
  • Dividend Yield
  • FGEN N/A
  • CYN N/A
  • EPS Growth
  • FGEN N/A
  • CYN N/A
  • EPS
  • FGEN N/A
  • CYN N/A
  • Revenue
  • FGEN $7,346,000.00
  • CYN $434,837.00
  • Revenue This Year
  • FGEN N/A
  • CYN $31.96
  • Revenue Next Year
  • FGEN N/A
  • CYN $1,459.25
  • P/E Ratio
  • FGEN N/A
  • CYN N/A
  • Revenue Growth
  • FGEN N/A
  • CYN 445.29
  • 52 Week Low
  • FGEN $4.50
  • CYN $3.62
  • 52 Week High
  • FGEN $21.94
  • CYN $1,312.50
  • Technical
  • Relative Strength Index (RSI)
  • FGEN 50.35
  • CYN 40.74
  • Support Level
  • FGEN $10.59
  • CYN $4.45
  • Resistance Level
  • FGEN $11.22
  • CYN $5.09
  • Average True Range (ATR)
  • FGEN 0.52
  • CYN 0.36
  • MACD
  • FGEN -0.00
  • CYN -0.03
  • Stochastic Oscillator
  • FGEN 58.60
  • CYN 13.60

About FGEN FibroGen Inc

FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The company operates in one reportable segment: the development and commercialization of novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates. Geographically, it operates in United States, Japan, Europe and Others.

About CYN Cyngn Inc.

Cyngn Inc is an industrial autonomous vehicle technology company. Its flagship innovation is DriveMod, an autonomous driving solution that can be flexibly deployed on multiple vehicle types manufactured by Original Equipment Manufacturers in various environments.

Share on Social Networks: